10.24335/L28681
RoyaltyStat
Exclusive assignment of all interest in patents, with nonexclusive know-how and process license to research, develop, make, have made, use, offer, sell, import, export and sublicense products and pharmaceutical compositions related to gene therapy methods for delivering stem cell factor coding sequences to treat ischemic diseases, for all fields.
RoyaltyStat
2014